Correlations of hepatitis B virus preS1-antigen with HBV-DNA,HBV-markers and liver function in patients with hepatitis B
Correlation Among PreS1,HBeAg and HBV-DNA in Patient with Hepatitis B
Conclusion: Lamivudine treatment could decrease the HBV-DNA and transaminase level, and delay the progression of liver fibrosis and lighten inflammation and necrosis of liver.
目的研究乙型肝炎病毒血清标志物、前S原检出情况与HBV-DNA结果之间的关系。
The Amdlysis Of the relationship Between the HBV Serological Markers and the HBV-DNA Detected by FQ-PCR
目的探讨HBV携带产妇血清、乳汁HBV-DNA载量的不同状况与实施母乳喂养安全*的关系。
The relationship of HBV PreS1-Ag and HBV-DNA、HBV-M in patients with hepatitis B virus infection
Correlation of detecting results of HBV-DNA and Pre-S_2 protein in diagnosis of hepatitis B virus infection
Hepatitis B Virus preS1-antigen HBV-DNA,and HBV Markers in Patients with Hepatitis B:Correlation Studies
应用反向间接血凝试验（RPHA）、酶免疫测定（EIA）和聚合酶链反应（PCR）测定了家禽血清、卵黄和牛乳清中HBV标志物及人HBV-DNA。
Correlation between PreS1-Ag,HBeAg and HBV-DNA in the Serum of Chronic Hepatitis B patients
定量检测外周血HBV-DNA可以直接反应HBV在血液中的复制情况，既而能够较为准确地解释感染HBV后的传染*。
